Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlling gene expression with 2-5A antisense.

D W Leaman1, H Cramer

  • 1Gemini Technologies Inc., 11,000 Cedar Avenue, Suite 140, Cleveland, Ohio 44106, USA. dougl@geminitech.com

Methods (San Diego, Calif.)
|August 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized controlled trial of acupuncture and receptive music therapy for sleep disorders in the elderly-ELAMUS: study protocol.

BMC complementary medicine and therapies·2024
Same author

Homeopathy for seasonal allergic rhinitis: rationale, design and methods of the three-armed randomized controlled HOMEOSAR trial.

BMC complementary medicine and therapies·2022
Same author

Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial.

European review for medical and pharmacological sciences·2022
Same author

Evidence on yoga for health: A bibliometric analysis of systematic reviews.

Complementary therapies in medicine·2021
Same author

Pathways to post-traumatic growth in cancer patients: moderated mediation and single mediation analyses with resilience, personality, and coping strategies.

Journal of affective disorders·2020
Same author

Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trials.

Trials·2020
Same journal

An accessible, absorbance-based plate reader assay to assess cumulative exposure of blood plasma & serum to thawed conditions.

Methods (San Diego, Calif.)·2026
Same journal

EC-isHCR: A rapid method for in situ hybridization chain reaction in diverse animal samples.

Methods (San Diego, Calif.)·2026
Same journal

Single-Molecule methods to investigate mechanisms of transcription by RNA polymerase of Mycobacterium tuberculosis.

Methods (San Diego, Calif.)·2026
Same journal

Detection and sequencing of Usutu virus during mosquito surveillance: Use of multiple assays and techniques for identification at low levels.

Methods (San Diego, Calif.)·2026
Same journal

Experimental validation of an AI-driven digital healthcare platform for oral health behavior and plaque assessment among vietnamese children.

Methods (San Diego, Calif.)·2026
Same journal

Zeta potential: An efficient and cost-effective alternative for investigating cell-surface interactions.

Methods (San Diego, Calif.)·2026
See all related articles

Synthetic 2

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Antisense Technology

Background:

  • Ribonuclease L (RNase L) is a cellular enzyme.
  • RNase L activation depends on 2',5'-linked oligoadenylates (2-5A).
  • 2-5A is typically produced during viral infections.

Purpose of the Study:

  • To describe the synthesis of chimeric 2-5A antisense molecules.
  • To provide examples of 2-5A antisense strategy applications.
  • To discuss RNase L's role in 2-5A antisense effects.

Main Methods:

  • Conjugation of synthetic 2-5A to antisense compounds.
  • Optimization of compound uptake and cellular effect analysis.
  • Synthesis procedure for chimeric 2-5A antisense molecules.

Related Experiment Videos

Main Results:

  • Successful applications of the 2-5A antisense strategy demonstrated.
  • Evidence supporting RNase L as the primary mediator of 2-5A antisense effects.
  • Methods for optimizing compound delivery and cellular analysis.

Conclusions:

  • The 2-5A antisense strategy offers an alternative to RNase H-dependent RNA degradation.
  • RNase L-dependent RNA cleavage is a viable therapeutic approach.
  • Further implications for future therapeutic strategies are discussed.